Past Distinguished Abstract Awards

2012 NACB Distinguished Abstract Awards

The National Academy of Clinical Biochemistry is pleased to announce the winners of the 2012 Distinguished Abstracts Awards. A group of NACB Fellows selected these 32 abstracts for their scientific excellence from a pool of 888 abstracts accepted for the AACC Annual Meeting.
Winning abstracts will display the NACB blue ribbon during the AACC Annual Meeting poster sessions in Los Angeles, CA.

A-18       Jaroslav Racek, Pilsen, Czech Republic

Lipoprotein-associated phospholipase A2 in hemodialysis patients and its relation to their prognosis and other risk factors of cardiovascular diseases

A-34       Roy Peake, Boston, MA

High sensitivity troponin and 5 year mortality in hemodialysis patients

A-52       John Rodriguez, Benicia, CA

Improved uniformity in a serological assay for anti-Sm by treatment of Sm autoantigen with RNase

A-119    Kazuhiko Kotani, MD, PhD, Jichi Medical University, Shimotsuke-City, Tochigi, Japan

The association between fasting plasma glucose and serum oxidized high-density lipoprotein levels in patients with dyslipidemia

A-141    Werner Steimer, MD, Munich, Germany

The human melanocortin four receptor gene: A new candidate gene for second generation antipsychotic-related weight gain?

A-142    Ping Wang, PhD, The Methodist Hospital, Houston, TX

MiRNA profile associated with chronic calcineurin inhibitor nephrotoxicity in renal transplant biopsies

A-161    Mark Borgman, PhD, Louisville, KY

The SLC6A4 Long A>G polymorphism enhances the clinical sensitivity of SSRI poor-responder genotyping

B-130     Mei-Chia Wang, MS, Taoyuan County, Taiwan

Application of a PNA-clamping real-time PCR method to predict the response to tyrosine kinase inhibitors from pleural effusions of patients with non-small-cell lung cancer

C-09       Cecilia Fernandez, PhD, Lexington, MA

Next-gen deep sequencing improves FGFR3 mutation detection in the urine of bladder cancer patients

C-25       Andreas Scorilas, PhD, Athens, Greece

Kallikrein-related peptidase 4 (KLK4) mRNA expression: a novel molecular tissue biomarker for the prediction of short-term relapse in colorectal adenocarcinoma

C-27       Emmanuel Fragoulis, PhD, University of Athens, Athens, Greece

miR-145 and its target, L-Dopa Decarboxylase (DDC), are promising prognostic biomarkers for the disease-free survival of prostate cancer patients

C-52       Lia Back, Florianópolis, Brazil

Association between an obesity-related gene and breast cancer risk

C-57       Brian Netzel, Mayo Clinic, Rochester, MN

Examination of thyroglobulin iodination states and quantitative usefulness for clinical thyroid cancer diagnostics

C-128     Mikio Watanabe, MD, PhD, Suita, Japan

Functional polymorphisms in TBX21 and HLX are associated with development and prognosis of Graves' disease

C-141     Torsten Matthias, PhD, Oakland, CA

Biomarker for spondyloarthritis: Autoantibodies against Class II-associated invariant chain peptide (CLIP)

C-193     Yves Giguère, MD, PhD, Québec, QC Canada

Candidate clinical factors and biomarkers for early prediction of preeclampsia: performance of a multivariate algorithm in a low-risk population

D-53       Zachary Godwin, Davis, CA

Hematocrit effects lead to inadequate glycemic control and insulin dosing in adult burn patients

D-79       Eduardo Martínez Morillo, PhD, Toronto, ON Canada

Kallikrein 6 as a serum prognostic marker in patients with aneurysmal subarachnoid hemorrhage

D-98       Alexander Gilmanov, MD, PhD, Russian Federation

NGAL vs. other biomarkers of kidney injury during lithotripsy

D-107    Douglas Stickle, PhD, Jefferson University Hospital, Philadelphia, PA

Receiver-operator characteristics of adjusted urine oxycodone measurements to distinguish between three different rates of drug administration

D-128    Ashley Ward, MD, Boston, MA

Free phenytoin: to measure or to calculate?

E-04       Ioannis Papassotiriou, PhD, Athens, Greece

Association of inflammation, endothelial dysfunction and angiogenesis in patients with thalassemia intermedia

E-20       Amy Pyle, PhD, Nationwide Children’s Hospital, Columbus, OH

Development and implementation of a method to measure hemoglobin in dried blood spots

E-26       Archana Agarwal, MD, Salt Lake City, UT

Identification of low concentration of Hb H by isoelectric focusing in alpha thalassemia with one or two alpha chain deletions

E-44       Jane Dickerson, PhD, University of Washington, Seattle, WA

A door not closed: a systematic review of unacknowledged send-out results

E-60       Jackie Coleman, PhD, Accumetrics, San Diego, CA

An economic model incorporating a point of care platelet function assay: a quality improvement and value assessment tool

E-65       Lei Stones Chen, University of Washington, Seattle, WA

A web-based route planning tool for transporting laboratory specimens

E-159     Erna Lenters-Westra, Zwolle, Netherlands

Interpretation of hemoglobin A1c values among different health care professionals

E-167     Jennifer McDonald, PhD, Mayo Clinic, Rochester, MN

Has the incidence of intravenous contrast induced nephropathy been overestimated?

E-179     Konstantinos Makris, PhD, Athens, Greece

Glial Fibrillary Acidic Protein (GFAP) levels on admission differentiate between ischemic stroke (IS) and intracerebral hemorrhage (ICH) and correlate with severity and outcome among  ICH patients

E-185     John Kalns, PhD, San Antonio, TX

Search for a novel salivary biomarker candidate for with chronic fatigue syndrome

E-202     Eberhard Spanuth, Heidelberg, Germany

Incremental prognostic value of High-Sensitivity Troponin T in mortality risk prediction of stable coronary artery disease

 

2010 NACB Distinguished Abstract Awards

The National Academy of Clinical Biochemistry is pleased to announce the winners of the 2011 Distinguished Abstracts Awards. A group of NACB Fellows selected these abstracts for their scientific excellence from a pool of 742 abstracts accepted for the AACC Annual Meeting.

Winning abstracts will display the NACB blue ribbon during the AACC Annual Meeting poster sessions in Atlanta, GA

A93 Eric Klee, PhD, Virginia Commonwealth University, Richmond, VA 
Changes in specimen mislabeling rate with educational intervention.
A129 Denise L. Uettwiller-Geiger, Mather Memorial Hospital, Port Jefferson, NY
The clinical laboratory’s critical role in decreasing Methicillin-resistant Staphylococcus aureus (MRSA) hospital acquired infection (HAI) by implementing a rapid screening program in a community hospital.
B31 Christopher R. McCudden, University of North Carolina, Chapel Hill, NC
Multivariate analysis of laboratory data for classification of patients with disorders of calcium homeostasis.
B92 Grigory Tsaur, Regional Children’s Hospital #1, Yekaterinburg, Russian Federation
Time to complete molecular remission corresponds to outcome in infant acute lymphoblastic leukemia with MLL gene rearrangements.
B124 Jian-Qing He, University of British Columbia, Vancouver, BC, Canada
Genetic variants of transcription nuclear factor (NF)-kappaB and atopic diseases.
B129 Lei Zhang, West China Hospital of Sichuan University, Chengdu, China
Branched DNA based quantitative detection of plasma Alu DNA in severe acute pancreatitis.
B164 Svetlana A. Dambinova, Kennesaw University, Kennesaw, GA
European multicenter evaluation of the NR2 peptide and antibody biomarkers for hyper-acute stroke within 4 hours of onset.
C23 Luke Chen, Pharmigene, Palo Alto, CA
A prospective study of the use of HLA-B*1502 genotyping in preventing carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
C52 J. Ordonez-Llanos, Hospital de Sant Pau, Barcelona, Spain
High-sensitivity troponin T will modify the clinical classification of acute coronary syndromes.
C54 J. Ordonez-Llanos, Hospital de Sant Pau, Barcelona, Spain
High-sensitivity troponin T will modify the clinical classification of acute coronary syndromes.
C54 Petr Jarolim, Brigham and Women’s Hospital, Boston, MA
Metalloproteinase PAPP-A and outcomes in patients with ACS: Initial observations from the MERLIN-TIMI 36 trial.
C56 Pete Kavsak, McMaster University, Hamilton, ON, Canada
Absolute increase in cardiac troponin I concentration determined with a research high sensitivity assay and health outcomes in a chest pain population.
C63 Alessandra Barassi, Ospedale San Paolo and University of Milan, Milan, Italy
High-sensitivity cardiac troponin is the most powerful prognostic determinant and predicts progression of cardiac dysfunction in AL amyloidosis.
C70 Mary Ann M. Murakami, Hennepin County Medical Center, Minneapolis, MN
Multiple biomarkers of various pathophysiologic pathways to determine relationships for diagnosis of myocardial infarction and adverse outcomes in patients presenting with symptoms of acute coronary syndrome.
C86 Adina E. Stanciu, Institute of Oncology, Bucharest, Romania
Anti-inflammatory and anti-remodeling effects of cardiac resynchronization therapy.
C93 Petr Jarolim, Brigham and Women’s Hospital, Boston, MA
Serum levels of both cardiac troponins T and I are associated with renal disease progression in patients with diabetes mellitus, anemia, and chronic kidney disease.
D11 Paul O. Collinson, St. George’s Hospital, London, UK
The RATPAC Trial (Randomized Assessment of Treatment using Panel Assay of Cardiac markers): A randomized controlled trial of point-of-care cardiac markers in the emergency department.
D101 Hendrick E. van Deventer, National Institutes of Health, Bethesda, MD
Direct LDL-C methods do not significantly improve cardiovascular risk classification over calculated LDL-C or Non-HDL-C when compared to the reference measurement procedure
D107 Alexander Popov, Ural State Medical Academy, Yekaterinburg, Russian Federation
Comparison of minimal residual disease data, assessed by flow cytometry and PCR of fusion gene transcripts in childhood b-cell precursor acute lymphoblastic leukemia.
D124 William L. Roberts, University of Utah, Sal Lake City, UT
Effect of race and age on prostate cancer detection using a combination [-2]proPSA, PSA, and Free PSA using the Beckman Coulter Access Immunoassay Systems. A multi-center prospective clinical study.
D135 Dennis J. O’Rourke, Brigham and Women’s Hospital, Boston, MA
Autoantibody signatures and immune complexes as potential biomarkers in ovarian cancer with low serum CA-125.
D146 Joonseok Park, Abbott Diagnostics, Seoul, Republic of Korea
Serum concentrations of human epididymis protein 4 (HE4) in women with ovarian cancer.
D158 Matthew P. Henderson, McMaster University, Hamilton, ON, Canada
Cytokines and cell adhesion molecules exhibit distinct profiles in health, ovarian cancer, and breast cancer.
D173 Joely A. Straseski, Johns Hopkins Medical Institutions, Baltimore, MD
Optimizing analytical assay performance for biomarker discovery and validation: A study of autoantibody biomarkers for the early detection of colorectal cancer.
D177 Murtaza Hadi, King’s College London, London, UK
Identification of a variant S100B (vS100B), a unique, single EF-hand, member of the S100 family of proteins.
E120 Roy R. Gerona, San Francisco General Hospital, San Francisco, CA
Clinical utility of an LC-MS/TOF seizure panel in emergency department's seizure patients.

 

2009 NACB Distinguished Abstract Awards

The National Academy of Clinical Biochemistry is pleased to announce the winners of the 2009 Distinguished Abstract Awards. 825 abstracts accepted for the AACC Annual Meeting were submitted to a second scientific review by a group of NACB Fellows and 22 were identified as representing outstanding research worthy of special recognition. 

Winning abstracts displayed the NACB blue ribbon during the Annual Meeting poster sessions in Chicago.

A-3 Tuesday, July 21, 10:00 am
Tania S. Frode

Down-regulation of Antioxidant Status and Lipid Peroxidation in the Inflamed Pleural Cavity of Mice Treated with Mycophaenolate Mofetil
A-31 Tuesday, July 21, 10:00 am
Raffick A.R. Bowen

Improvements in Turnaround Time (TAT) after Computerized Autoverification in a Rapid Response Clinical Chemistry Laboratory
 B-77 Tuesday, July 21, 2:00 pm
Ioannis Papassotiriou

Soluble Endoglin and Its Interaction with Adhesion Molecules in Patients with Thalassemia Intermedia
 B-87 Tuesday, July 21, 2:00 pm
Debra A. Hoppensteadt
Activation of Prekallikrein by Contaminated Heparins, Isolated Contaminant and Related Hypersulfated Chondroitin Sulfate Preparations: Pharmacologic Implications
 B-94 Tuesday, July 21, 2:00 pm
Jamila Hirbawi

The Function of Acidic Amino Acid Region 659-663 of Factor Va on Prothrombinase during Prothrombin Activation
B-114 Tuesday, July 21, 2:00 pm
Andrew N. Hoofnagle 

Clinical Lipoproteomics Unveils Clusterin as a Novel Biomarker of Insulin Resistance
B-129 Tuesday, July 21, 2:00 pm
Stacy J. Hartman

Elevated C-Reactive Protein is Associated with Elevated LDL Particle Concentration in Patients with Normal Calculated LDL Cholesterol
C-13 Wednesday, July 22, 10:00 am
Rasha M. AlKhaldi

Adipokines and Adiponectin Gene Single Nucleotide Polymorphisms as Potential Links between Obesity and Cancer
 C-28 Wednesday, July 22, 10:00 am
Mathias Gehrmann

Prognosis of Distant Metastasis in Node-Negative Early Breast Cancer
C-34 Wednesday, July 22, 10:00 am
John R. Petersen

A New Biomarker Panel to Predict Hepatocellular Carcinoma in Chronic HCV Patients
D-52 Wednesday, July 22, 2:00 pm
Alessandra Barassi

Fecal Calprotectin Levels in Patients with Colonic Polyposis
D-141 Wednesday, July 22, 2:00 pm
Matthew P. Thompson

The Correlation of Peroxiredoxin Levels and Pain in Patients with Varicella Zoster Reactivation: A Novel Biomarker for Postherpatic Neuralgia
D-148 Wednesday, July 22, 2:00 pm
Mario Plebani  

Determination of Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA) in Human Plasma: Analytical and Clinical Validation
D-151 Wednesday, July 22, 2:00 pm
Maria C. Gonzalez Mao    

S100B Protein as a Serum Marker of Survival After Traumatic Brain Injury (TBI)e
D-157 Wednesday, July 22, 2:00 pm
Svetlana A. Dambinova 

Diagnostic Values of NMDA Receptor Peptide for Acute Ischemic Stroke
E-31 Thursday, July 23, 2009 10:00 am
Ming Guan 

Quantitative Determination of Methylation Level of DLC-1 Promoter with Methylation-Sensitive High-Resolution Melting in Prostate Cancer
E-42 Thursday, July 23, 2009 10:00 am
Ellen Umlauf
 
Implication of Wild Type Glutathione S-Transferase Omega-1 as a Risk Factor in Non-APOE4 Carriers in Alzheimer's Disease
E-47 Thursday, July 23, 2009 10:00 am
Ping Wang
 
Using Genetic and Clinical Factors to Predict Tacrolimus Dose in Renal Transplant Recipients
E-89 Thursday, July 23, 2009 10:00 am
Alison Woodworth 

Cervicovaginal Interleukin-6 is a Predictor of Preterm Birth in African American but Not Caucasian Women
E-95 Thursday, July 23, 2009 10:00 am
Angela M. Ferguson 

The Impact of Creatinine Standardization on Dosing of Chemotherapy Drugs that are Based on Creatinine Clearance
E-141 Thursday, July 23, 2009 10:00 am
Ron Schifman 

Association of Drugs of Abuse Urine Testing with Risk of Hepatitis C Infection
E-161 Thursday, July 23, 2009 10:00 am
Pierre Olivier Hétu

Ion Suppression Observed During Quantification of the Immunosuppressants in Blood by LC-MS/MS is Significantly Reduced by the Addition of Divalent Cations in the Extract after Protein Precipitation

 

2008 NACB Distinguished Abstract Awards

A panel of NACB Fellows has selected the following 26 abstracts out of 725 accepted for the AACC Annual Meeting as representing scientific excellence worthy of special recognition. The abstracts will display the NACB blue ribbon. 

A-97 Tuesday, July 29, 10:00 a.m.
John Ferrara
The role of procalcitonin in the diagnosis of sepsis and patient assignment to medical intensive care.
A-99 Tuesday, July 29, 10:00 a.m.
Amy Mondelblatt 
Traditional High Resolution CSF Protein Electrophoresis Is Ineffective in Detecting Oligoclonal Banding 
A-113 Tuesday, July 29, 10:00 a.m.
Qing H Meng
Transforming growth factor-β1 is a potential marker for kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker
A-120 Tuesday, July 29, 10:00 a.m.
Paul R Desjardins 
Comparing the clinical effectiveness of Fetal Fibronectin and IGFBP-1 measurements in cervico-vaginal secretions, in predicting preterm deliveries.
B-27 Tuesday, July 29, 2:00 p.m.
Lorin M Bachmann
A novel proteomics platform for LC-Tandem MS-based quantification of differentially expressed proteins in complex biofluids.
B-41 Tuesday, July 29, 2:00 p.m.
John R Petersen
Evaluation of the APRI (AST, platelet ratio index) and ELF™ (Enhanced Liver Fibrosis) Tests to detect significant fibrosis due to Chronic Hepatitis C.
B-65 Tuesday, July 29, 2:00 p.m.
Qing H Meng
Beneficial Effects of Soy Isoflavones on Insulin Secretion, Glucose Control, and Cataract Prevention in Streptozotocin-induced Diabetic Rats
B-80 Tuesday, July 29, 2:00 p.m.
Larry H Bernstein
Correcting NT-ProBNP Level for Effect of Renal Function Impairment
B-134 Tuesday, July 29, 2:00 p.m.
Pete Kavsak 
Preliminary investigation of a high sensitivity PAPP-A research assay in an Acute Coronary Syndrome population
B-141 Tuesday, July 29, 2:00 p.m.
Alexander Semenov
The difference in glycosylation between human proBNP and NT-proBNP suggests a new regulatory level in proBNP processing
B-146 Tuesday, July 29, 2:00 p.m.
Paul O Collinson 
The second International COllaborative study of N-terminal pro B type natriuretic peptide NTproBNP in Primary Care (ICON II-PC).
B-153 Tuesday, July 29, 2:00 p.m.
Amy K Saenger 
Modulation and Relationship of Brain Natriuretic Peptides to Estrogen and Androgens, as Investigated in a Pediatric Population 
B-157 Tuesday, July 29, 2:00 p.m.
Jordi Ordonez-Llanos 
A Formula Combining ST2 and NT-proBNP Enhances Prognostic Accuracy in Patients with Heart Failure
C-10 Wednesday, July 30, 10:00 a.m.
Naohito Ishii 
Hemodialysis suppresses nitrotyrosine residue formation in patients with diabetes mellitus
C-42 Wednesday, July 30, 10:00 a.m.
Zhimin Cao
Poor interlaboratory agreement of testosterone measurements using HPLC-tandem mass spectrometry 
C-70 Wednesday, July 30, 10:00 p.m.
Jagadish Ulloor
Dynamics of testosterone and SHBG interaction
D-29 Wednesday, July 30, 2:00 p.m.
Johan Frostegård
Low Levels of Antibodies Against Phosphorylcholine Predict Development of Atherosclerosis.
D-32 Wednesday, July 30, 2:00 p.m.
Amar A Sethi
Pre-beta HDL is a Strong Positive Diagnostic Risk Marker for Ischemic Heart Disease in Subjects with both High and Low HDL-C Levels.The Copenhagen City Heart Study. 
D-52 Wednesday, July 30, 2:00 p.m.
Werner Steimer
Influence of Cyp1A2*1F polymorphism on olanzapine serum concentrations and clinical outcome 
D-54  Wednesday, July 30, 2:00 p.m.
Werner Steimer 
Influence of Cyp2C19 polymorphisms on citalopram serum concentrations and clinical outcome
D-70 Wednesday, July 30, 2:00 p.m.
Kristen K. Reynolds
Accuracy of genotype-based warfarin dose estimation and plasma S-warfarin pharmacokinetic modeling
D-104 Wednesday, July 30, 2:00 p.m.
Alexander Haliassos
Early Markers of Acute Kidney Injury in ICU multitrauma patients. Preliminary report.
D-147 Wednesday, July 30, 2:00 p.m.
Michael I. Watkins 
Hemolysis Interference Does Not Equal Hemoglobin Interference; Non-Hemoglobin Interference by the Hemolysate of Red Blood Cells (RBC)
E-10 Thursday, July 31, 10:00 a.m.
Mark A Cervinski
Qualitative Point-of-Care (POC) and Over-the-Counter (OTC) Urine hCG Devices Detect Various Isoforms of hCG During Early Pregnancy.
E-22 Thursday, July 31, 10:00 a.m.
Soumaya El Rouby 
Monitoring Heparin Therapy during Cardiopulmonary Bypass and Cardiac Interventional Catheterization in Pediatrics
E-95 Thursday, July 31, 10:00 a.m.
Shu-Ling Liang
Falsely-Elevated Acetaminophen Results in Icteric and Hemolyzed Specimens
Page Access: